Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers

Completed · Not applicable

Conditions studied: Irritable Bowel Disease

In brief

To assess the differential expression of IBD-related microbiome-derived biomarkers including bacterial strains and peptides such as antimicrobial peptides (AMP) found in inner-colonic samples (HygiSample™) in comparison to home collected stool samples in patients with active IBD colonic disease. The HygiSample will be collected during a defecation-inducing high-volume (\>40 L) colon irrigation bowel prep (HygiPrepⓇ).

Key facts

Study ID
NCT05640583
Run by
HyGIeaCare, Inc.
People needed
20
Starts
2022-03-16
Expected to finish
2023-03-06
Last updated by the study team
2023-04-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.